Isoxazolinyl Spironucleosides: Stereoselectivity of 1,3-Dipolar Cycloadditions of 7-Methylenepyrrolo[1,2-c]pyrimidin-1(5H)-ones

Róbert Fischer; Eva Hýrošová; Alexandra Drucková; Lubor Fišera; Christian Hametner; Michał K. Cyrański

doi:10.1055/s-2003-42112

LETTER

Isoxazolinyl Spironucleosides: Stereoselectivity of 1,3-Dipolar Cycloadditions of 7-Methylenepyrrolo[1,2-c]pyrimidin-1(5H)-ones

Róbert Fischer^a, Eva Hýrošová^a, Alexandra Drucková^a, Lubor Fišera*^a, Christian Hametner^b, Michał K. Cyrański^c
^a Department of Organic Chemistry, Slovak University of Technology, 812 37 Bratislava, Slovak Republic
e-Mail: fisera@cvt.stuba.sk;
^b Institute of Applied Synthetic Chemistry, University of Technology, 1060 Vienna, Austria
^c Department of Chemistry, University Warsaw, 02 093 Warsaw, Poland

Abstract

Alle Artikel dieser Rubrik

Abstract

Novel 7-methylenepyrrolo[1,2-c]pyrimidin-1(5H)-ones 11a-c were synthesized from commercially available orotic acid (6). 1,3-Dipolar cycloadditions of mesitonitrile oxide to the exocyclic double bond of the dipolarophiles 11 proceed with complete regioselectivity and lead to the spiroisoxazolinyl nucleosides 13 and 14 in good yields. Attack of the dipole from the less sterically hindered side of the dipolarophile affords C-5/C-7 trans isoxazolines as major isomers predominantly. The protection of the free hydroxyl group by the bulky substituent (TBDPS) leads to formation C-5/C-7 trans isomer 14c exclusively.

Key words

pyrrolo[1,2-c]pyrimidin-1(5H)-ones - dipolar cycloadditions - nitrile oxides - isoxazolines - modified spironucleosides

Volltext

Referenzen

References

<A NAME="RD17103ST-1">1</A> Haruyama H. Takayama T. Kinoshita T. Kondo M. Nakajima M. Haneishi T. J. Chem. Soc., Perkin Trans. 1 1991, 1637

<A NAME="RD17103ST-2A">2a</A> Kittaka A. Tanaka H. Odanaka Y. Ohnuki K. Yamaguchi K. Miyasaka T. J. Org. Chem. 1994, 59: 3636

<A NAME="RD17103ST-2B">2b</A> Kittaka A. Asakura T. Kuze T. Tanaka H. Yamada N. Nakamura KT. Miyasaka T. J. Org. Chem. 1999, 64: 7081

<A NAME="RD17103ST-2C">2c</A> Chatgilialoglu C. Gimisis T. Spada GP. Chem.-Eur. J. 1999, 5: 2866

<A NAME="RD17103ST-3">3</A> Yoshimura Y. Otter BA. Ueda T. Matsuda A. Chem. Pharm. Bull. 1992, 40: 1761

<A NAME="RD17103ST-4A">4a</A> Merino P. Curr. Med. Chem. -Anti-Infective Agents 2002, 1: 389

<A NAME="RD17103ST-4B">4b</A> Pan S. Amankulor NM. Zhao K. Tetrahedron 1998, 54: 6587

<A NAME="RD17103ST-5A">5a</A> Merino P. Franco S. Merchan FL. Tejero T. J. Org. Chem. 2000, 65: 5575

<A NAME="RD17103ST-5B">5b</A> Chiacchio U. Rescifina A. Corsaro A. Pistara V. Romeo G. Romeo R. Tetrahedron: Asymmetry 2000, 11: 2045

<A NAME="RD17103ST-5C">5c</A> Merino P. Del Alamo EM. Franco S. Merchan FL. Simon A. Tejero T. Tetrahedron: Asymmetry 2000, 11: 1543

<A NAME="RD17103ST-5D">5d</A> Colacino E. Coverso A. Liguori A. Napoli A. Siciliano C. Sindona G. Tetrahedron 2001, 57: 8551 ; and references cited therein

<A NAME="RD17103ST-6A">6a</A> Dalpozzo R. De Nino A. Maiuolo L. Procopio A. De Munno G. Sindona G. Tetrahedron 2001, 57: 4035

<A NAME="RD17103ST-6B">6b</A> Iannazzo D. Piperno A. Pistara V. Rescifina A. Romeo R. Tetrahedron 2002, 58: 581

<A NAME="RD17103ST-6C">6c</A> Chiacchio U. Corsaro A. Iannazzo D. Piperno A. Pistara A. Procopio A. Rescifina A. Romeo G. Romeo R. Siciliano MCR. Valveri E. Arkivoc 2002, 159

<A NAME="RD17103ST-7A">7a</A> Chiacchio U. Corsaro A. Iannazzo D. Piperno A. Rescifina A. Romeo R. Romeo G. Tetrahedron Lett. 2001, 42: 1777

<A NAME="RD17103ST-7B">7b</A> Iannazzo D. Piperno A. Pistara V. Rescifina A. Romeo R. Tetrahedron 2002, 58: 581

<A NAME="RD17103ST-8A">8a</A> Fischer R. Drucková A. Fiera L. Rybár A. Hametner C. Cyránski MK. Synlett 2002, 1113

<A NAME="RD17103ST-8B">8b</A> Fischer R. Drucková A. Fiera L. Hametner C. Arkivoc 2002, 80

<A NAME="RD17103ST-9">9</A> Gershon H. J. Org. Chem. 1962, 27: 3507

<A NAME="RD17103ST-10">10</A> Aldehyde 8 was prepared from 7 by a two-steps process via selective oxidation of the corresponding alcohol in 84% yield: Snider BB. Chaoyu X. Tetrahedron Lett. 1998, 39: 7021

<A NAME="RD17103ST-11">11</A> Danel K. Pedersen EB. Nielsen C. Synthesis 1997, 1021

Procedure for 2,4-Dimethoxy-6-(1-hydroxybut-3-en-1-yl)pyrimidine ( 9a): To a stirred suspension of Zn dust (1.98 g, 7.33 mmol) in anhyd THF (50 mL), allyl bromide (1.62 mL, 18.07 mmol) was added, followed by 2,4-dimethoxy-6-pyrimidinecarbaldehyde (8, 0.60 g, 3.57 mmol) and the mixture was stirred vigorously under reflux for 3 h. The reaction mixture was cooled to r.t., quenched with sat. aq NH₄Cl and vigorously stirred with CH₂Cl₂ (30 mL) for 15 min. The solid was removed by filtration through the Celite^® and the organic layer was separated. The aq phase was extracted with CH₂Cl₂ (20 mL) and the combined organic layers were dried with Na₂SO₄, filtered and the solvent removed. The final product was purified by the column chromatography on silica gel (hexane-EtOAc, 3:1) giving homoallyl alcohol 9a (0.63 g) as a colourless solid; yield 85%; mp 131-133 °C. ¹H NMR (400 MHz, CDCl₃): δ = 2.46 (ddddd, J _7,8a = 7.3 Hz, J _8a,8b = 14.3 Hz, J _8a,9 = 7.3 Hz,
J _8a,10a = 1.2 Hz, J _8a,10b = 1.2 Hz, 1 H, H-8a), 2.63 (ddddd,
J _7,8b = 4.7 Hz, J _8a,8b = 14.0 Hz, J _8b,9 = 7.0 Hz, J _8b,10a = 1.5 Hz, J _8b,10b = 1.2 Hz, 1 H, H-8b), 3.37 (d, J _7,OH = 5.0 Hz, 1 H, OH), 3.97, 4.00 (2 × s, 2 × 3 H, OCH₃), 4.62 (ddd, J _7,OH = 4.7 Hz, J _7,8a = 7.6 Hz, J _7,8b = 4.7 Hz, 1 H, H-7), 5.13 (dddd, J _8a,10b = 1.2 Hz, J _8b,10b = 1.2 Hz, J _9,10b = 10.2 Hz, J _10a,10b = 1.8 Hz, 1 H, H-10b), 5.14 (dddd, J _8a,10a = 1.5 Hz, J _8b,10a = 1.5 Hz, J _9,10a = 17.0 Hz, J _10a,10b = 2.0 Hz, 1 H, H-10a), 5.81 (dddd, J _8a,9 = 7.0 Hz, J _8b,9 = 7.0 Hz, J _9,10a = 17.0 Hz, J _9,10b = 10.2 Hz, 1 H, H-9), 6.39 (d, J _5,7 = 0.6 Hz, 1 H, H-5). ¹³C NMR (125 MHz, CDCl₃): δ = 42.2 (C-8), 54.4, 55.2 (OCH₃), 72.2
(C-7), 97.9 (C-5), 119.0 (C-10), 133.9 (C-9), 165.4 (C-6), 172.5, 173.0 (C-2, C-4).

Procedure for 10a: The stirred solution of the homoallyl alcohol 9b (0.20 g, 0.64 mmol) in CHCl₃ (20 mL) was warmed to 60 °C and a solution of Br₂ (0.10 g, 0.03 mL, 0.64 mmol) in CHCl₃ (10 mL) was slowly added dropwise over 4 h. The solvent was removed in vacuo and the reaction products were isolated by column chromatography on silica gel (hexane-EtOAc, 1:1) giving pyrimidinone 10b as a mixture of cis/trans isomers (0.20 g, 82%) as colorless foam.

Selected data: 6,7-Dihydro-5-hydroxy-3-methoxy-7-methylenepyrrolo[1,2- c ]pyrimidin-1(5 H )-one ( 11a): Yield 44%; colorless solid; mp 192-193 °C. ¹H NMR (400 MHz, DMSO-d ₆): δ = 2.60 (dddd, J _5,6a = 6.1 Hz, J _6a,6b = 16.1 Hz, J _6a,10a = 2.1 Hz, J _6a,10b = 2.4 Hz, 1 H, H-6a), 3.07 (dddd, J _5,6b = 8.2 Hz, J _6a,6b = 16.1 Hz, J _6b,10a = 1.5 Hz, J _6b,10b = 1.8 Hz, 1 H, H-6b), 3.86 (s, 3 H, OCH₃), 4.89 (dd, J _6a,10a = 2.1 Hz, J _6b,10a = 1.5 Hz, J _10a,10b = 0 Hz, 1 H, H-10a), 4.98 (dddd, J _5,OH = 6.1 Hz, J _4,5 = 1.2 Hz, J _5,6a = 6.1 Hz, J _5,6b = 8.2 Hz, 1 H, H-5), 6.08 (d, J _4,5 = 1.2 Hz, 1 H, H-4), 6.10 (d, J _5,OH = 6.1 Hz, 1 H, OH), 6.14 (dd, J _6a,10b = 2.3 Hz, J _6b,10b = 1.8 Hz, 1 H, H-10b). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 38.2 (C-6), 55.1 (OCH₃), 68.0 (C-5), 91.5 (C-4), 99.1 (C-10), 143.1 (C-7), 154.2 (C-1), 164.7 (C-8), 171.6 (C-3). 6,7-Dihydro-5- tert -butyldiphenylsilyloxy-3-methoxy-7-methylenepyrrolo[1,2- c ]pyrimidin-1(5 H )-one ( 11b): Yield 66%; colorless syrup. ¹H NMR (400 MHz, CDCl₃):
δ = 1.10 [s, 9 H, OSiC(CH₃)₃], 2.68 (dddd, J _5,6a = 7.9 Hz, J _6a,6b = 15.2 Hz, J _6a,10a = J _6a,10b = 1.2 Hz, 1 H, H-6a), 2.76 (dddd, J _5,6b = 7.3 Hz, J _6a,6b = 15.2 Hz, J _6b,10a = J _6b,10b = 2.3 Hz, 1 H, H-6b), 3.95 (s, 3 H, OCH₃), 4.82 (ddd, J _6a,10a = J _10a,10b = 1.2 Hz, J _6b,10a = 2.1 Hz, 1 H, H-10a), 4.98 (ddd, J _4,5 = 1.2 Hz, J _5,6a = 7.9 Hz, J _5,6b = 7.3 Hz, 1 H, H-5), 5.77 (d, J _4,5 = 1.2 Hz, 1 H, H-4), 6.28 (ddd, J _6a,10b = J _10a,10b = 1.2 Hz, J _6b,10b = 2.3 Hz, 1 H, H-10b), 7.40-7.68 (m, 10 H, OSiPh₂). ¹³C NMR (125 MHz, CDCl₃): δ = 19.6 [OSiC(CH₃)₃], 27.2 [OSiC(CH₃)₃], 39.3 (C-6), 55.2 (OCH₃), 70.4 (C-5), 92.0
(C-4), 100.6 (C-10), 128.4, 128.5, 130.8, 132.7, 133.0, 136.1 (OSiPh₂), 141.3 (C-7), 154.8 (C-1), 161.9 (C-8), 171.6
(C-3). 6,7-Dihydro-5-benzoyloxy-3-methoxy-7-methylene-pyrrolo[1,2- c ]pyrimidin-1(5 H )-one ( 11c): Yield 80%; colorless syrup. ¹H NMR (400 MHz, CDCl₃): δ = 2.96 (dddd, J _5,6a = 4.6 Hz, J _6a,6b = 16.9 Hz, J = 1.8 Hz, J = 2.1 Hz, 1 H, H-6a), 3.33 (dddd, J _5,6b = 8.2 Hz, J _6a,6b = 16.9 Hz, J = 1.8 Hz, J = 2.1 Hz, 1 H, H-6b), 3.98 (s, 3 H, OCH₃), 5.01 (ddd, J _10a,10b = 1.2 Hz, J = 1.8 Hz, J = 2.1 Hz, 1 H, H-10a), 6.13 (d, J _4,5 = 0.9 Hz, 1 H, H-4), 6.19 (ddd, J _4,5 = 0.9 Hz,
J _5,6a = 4.6 Hz, J _5,6b = 8.2 Hz, 1 H, H-5), 6.46 (ddd, J _10a,10b = 1.2 Hz, J = 1.8 Hz, J = 2.1 Hz, 1 H, H-10b), 7.44-8.04 (m,
5 H, COPh). ¹³C NMR (125 MHz, CDCl₃): δ = 35.4 (C-6), 55.4 (OCH₃), 69.8 (C-5), 94.0 (C-4), 101.1 (C-10), 129.1, 130.3, 134.3 (COPh), 141.0 (C-7), 154.8 (C-1), 157.5 (COPh), 166.0 (C-8), 171.5 (C-3).

General Procedure: Mesitonitrile oxide 12 and 7-methylenepyrrolo[1,2-c]pyrimidin-1(5H)-one 11 were dissolved in 1,4-dioxane and stirred under reflux. When no starting material remained (TLC), the solvent was removed in vacuo and the products of the cycloaddition were isolated by column chromatography (hexane-ethyl acetate). Selected data: (5,7- trans )-4′,5′,6,7-Tetrahydro-3′-(2,4,6-trimethylphenyl)-3-methoxy-5-hydroxyspiro[pyr-rolo[1,2- c ]pyrimidine-7(5 H ),5′-izoxazol]-1-one ( 14a): Yield 42%; colorless solid; mp 241-243 °C. ¹H NMR (400 MHz, DMSO-d ₆): δ = 2.26 (s, 3 H, 4-CH₃Ph), 2.31 (s, 6 H, 2,6-CH₃Ph), 2.41 (dd, J _5,6a = 8.8 Hz, J _6a,6b = 13.7 Hz, 1 H, H-6a), 2.87 (dd, J _5,6b = 7.6 Hz, J _6a,6b = 13.7 Hz, 1 H, H-6b), 3.44 (d, J _4a _′ _,4b _′ = 18.7 Hz, 1 H, H-4a′), 3.85 (s, 3 H, OCH₃), 4.22 (d, J _4a _′ _,4b _′ = 18.7 Hz, 1 H, H-4b′), 5.13 (dddd, J _4,5 = 1.5 Hz, J _5,OH = 5.8 Hz, J _5,6a = 8.8 Hz, J _5,6b = 7.3 Hz, 1 H, H-5), 6.05 (d, J _4,5 = 1.2 Hz, 1 H, H-4), 6.29 (d, J _5,OH = 5.8 Hz, 1 H, OH), 6.93 (s, 2 H, Ph). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 20.4 (2,6-CH₃Ph), 21.5 (4-CH₃Ph), 46.3, 46.4 (C-6, C-4′), 55.1 (OCH₃), 68.4 (C-5), 90.7 (C-4), 102.6 (C-5′/C-7), 126.4 (C-4-Ph), 129.2 (CH-Ph), 137.7 (C-2,6-Ph), 139.1 (C-1-Ph), 153.8 (C-1), 158.4 (C-3′), 164.9 (C-4a), 173.1 (C-3).
(5,7- trans )-4′,5′,6,7-Tetrahydro-3′-(2,4,6-trimethyl-phenyl)-3-methoxy-5- tert -butyldiphenylsilyloxy-spiro[pyrrolo[1,2- c ]pyrimidine-7(5 H ),5′-izoxazol]-1-one ( 14c): Yield 79%; colorless solid; mp 214-215 °C. ¹H NMR (400 MHz, CDCl₃): δ = 1.12 [s, 9 H, OSiC(CH₃)₃], 2.28 (s, 3 H, 4-CH₃Ph), 2.37 (s, 6 H, 2,6-CH₃Ph), 2.32 (dd, J _5,6a = 8.8 Hz, J _6a,6b = 13.2 Hz, 1 H, H-6a), 2.67 (dd, J _5,6b = 7.3 Hz, J _6a,6b = 13.2 Hz, 1 H, H-6b), 3.09 (d, J _4a _′ _,4b _′ = 18.4 Hz, 1 H, H-4a′), 3.94 (s, 3 H, OCH₃), 4.52 (d, J _4a _′ _,4b _′ = 18.4 Hz, 1 H, H-4b′), 5.25 (ddd, J _4,5 = 1.2 Hz, J _5,6a = 8.8 Hz, J _5,6b = 7.3 Hz, 1 H, H-5), 5.77 (d, J _4,5 = 1.2 Hz 1 H, H-4), 6.89 (s, 2 H, H-Ph), 7.41-7.70 (m, 10 H, OSiPh₂). ¹³C NMR (125 MHz, CDCl₃): δ = 19.6 [OSiC(CH₃)₃], 20.4 (2,6-CH₃Ph), 21.5
(4-CH₃Ph), 27.3 [OSiC(CH₃)₃], 46.5, 47.6 (C-6, C-4′), 55.3 (OCH₃), 70.4 (C-5), 91.7 (C-4), 101.6 (C-5′/C-7), 125.5 (C-4-Ph), 128.5, 128.6, 129.0, 130.9, 131.0, 132.4, 132.8, 136.1 (CHPh, OSiPh₂), 137.8 (C-2,6-Ph), 139.4 (C-1-Ph), 154.3 (C-1), 158.2 (C-3′), 162.2 (C-4a), 173.2 (C-3).
(5,7- cis )-4′,5′,6,7-Tetrahydro-3′-(2,4,6-trimethylphenyl)-3-methoxy-5-benzoyloxyspiro[pyrrolo[1,2- c ]pyrimidine-7(5 H ),5′-izoxazol]-1-one ( 13b): Yield 14%; colorless solid; mp 164-165 °C. ¹H NMR (400 MHz, CDCl₃): δ = 2.30 (s, 3 H, 4-CH₃Ph), 2.43 (s, 6 H, 2,6-CH₃Ph), 2.85 (dd, J _5,6a = 7.0 Hz, J _6a,6b = 15.1 Hz, 1 H, H-6a), 2.99 (dd, J _5,6b = 2.3 Hz, J _6a,6b = 15.1 Hz, 1 H, H-6b), 3.23 (d, J _4a _′ _,4b _′ = 18.4 Hz, 1 H, H-4a′), 3.97 (s, 3 H, OCH₃), 4,50 (d, J _4a _′ _,4b _′ = 18.4 Hz, 1 H, H-4b′), 6.14 (d, J _4,5 = 0.9 Hz, 1 H, H-4), 6.22 (ddd, J _4,5 = 0.9 Hz, J _5,6a = 7.0 Hz, J _5,6b = 2.3 Hz, 1 H, H-5), 6.92 (s, 2 H, Ph), 7.45-8.11 (m, 5 H, COPh). ¹³C NMR (125 MHz, CDCl₃),
δ = 20.4 (2,6-CH₃Ph), 21.5 (4-CH₃Ph), 44.5, 46.9 (C-6, C-4′), 55.5 (OCH₃), 69.8 (C-5), 94.4 (C-4), 102.9 (C-5′/C-7), 125.4 (C-4-Ph), 129.0, 130.5, 134.3 (CHPh, COPh), 137.9 (C-2,6-Ph), 139.5 (C-1-Ph), 154.2 (C-1), 156.9 (COPh), 158.0 (C-3′), 166.2 (C-4a), 173.3 (C-3).
(5,7- trans )-4′,5′,6,7-Tetrahydro-3′-(2,4,6-trimethyl-phenyl)-3-methoxy-5-benzoyloxyspiro[pyrrolo[1,2- c ]pyrimidine-7(5 H ),5′-izoxazol]-1-one ( 14b): Yield 69%; colorless solid; mp 210-212 °C. ¹H NMR (400 MHz, CDCl₃): δ = 2.30 (s, 3 H, 4-CH₃Ph), 2.42 (s, 6 H, 2,6-CH₃Ph), 2.57 (dd, J _5,6a = 7.3 Hz, J _6a,6b = 14.0 Hz, 1 H, H-6a), 3.25 (d, J _4a _′ _,4b _′ = 18.4 Hz, 1 H, H-4a′), 3.34 (dd, J _5,6b = 7.6 Hz, J _6a,6b = 14.0 Hz, 1 H, H-6b), 3.98 (s, 3 H, OCH₃), 4.58 (d, J _4a _′ _,4b _′ = 18.1 Hz, 1 H, H-4b′), 6.06 (d, J _4,5 = 1.2 Hz, 1 H, H-4), 6.37 (ddd, J _4,5 = 1.2 Hz, J _5,6a = 7.3 Hz, J _5,6b = 7.6 Hz, 1 H, H-5), 6.92 (s, 2 H, H-Ph), 7.46-7.65 (m, 5 H, COPh). ¹³C NMR (125 MHz, CDCl₃): δ = 20.3 (2,6-CH₃Ph), 21.5 (4-CH₃Ph), 44.9, 47.0 (C-6, C-4′), 55.5 (OCH₃), 70.4 (C-5), 93.1 (C-4), 102.3 (C-5′/C-7), 125.4 (C-4-Ph), 129.0, 129.1, 130.3, 134.5 (CHPh, COPh), 137.9 (C-2,6-Ph), 139.6 (C-1-Ph), 154.2 (C-1), 157.7 (COPh), 158.2 (C-3′), 165.8 (C-4a), 173.2 (C-3).

<A NAME="RD17103ST-16A">16a</A> Pereira SM. Savage GP. Simpson GW. Greenwood RJ. Mackay MF. Aust. J. Chem. 1993, 46: 1401

<A NAME="RD17103ST-16B">16b</A> Fiera L. Jaroková L. Matejková I. Heimgartner H. Heterocycles 1995, 1: 271

<A NAME="RD17103ST-16C">16c</A> Micúch P. Fiera L. Ondru V. Ertl P. Molecules 1997, 2: 57

<A NAME="RD17103ST-16D">16d</A> Cheng W.-C. Liu Y. Wong M. Olmstead MM. Lam KS. Kurth MJ. J. Org. Chem. 2002, 67: 5673

<A NAME="RD17103ST-16E">16e</A> Melsa P. Mazal C. Collect. Czech. Chem. Commun. 2002, 67: 353

Crystallographic data for the structure 15 and 16 have been deposited with the Cambridge Crystallographic Data Centre. Copies of the data can be obtained on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (email: deposit@ccdc.cam.ac.uk).